Distributing Human Resources for Health: Ethics and Health Policy
Website: http://bit.ly/zP8eDN
Applications are accepted until 15 March 2012
Of all the resources needed to conquer AIDS, TB, Malaria, and the other great threats to human health in the developing world, none is more essential than the people – doctors, nurses, scientists, and many others – who together constitute the workforce of health systems. Like money, drugs and other key resources, they are scarce. In other respects, however, they stand out among resources for health, for unlike pills and euros they have rights, and minds of their own, and they don’t necessarily go where health resource allocators want to send them.
The ethical issues that must be faced in responding to the critical shortage of trained health professionals in countries bearing the greatest burden of disease are likewise distinctive. Even the richest countries are short, and they are filling empty posts by offering jobs to well-trained health workers in the poorest countries. In the latter, lower incomes and difficult working conditions provide motivation to emigrate to where pay is higher, some research and career opportunities are more available, and living can be easier. This may enhance health workers’ job prospects and the quality of their lives, but the cumulative effect on the health of the populations they leave behind can be devastating. Medical brain drain flows virtually in one direction only; doctors, nurses, and scientists from wealthy countries do not clamour for appointments in the poor ones.
This ethical challenge will be addressed at the 2012
The
ORGANISERS
Samia Hurst,
Nir Eyal,
Dan Wikler,
CONFIRMED SPEAKERS
Dan Brock,
Simon Caney,
Michael Clemens, Center for Global Development
Mario Dal Poz, World Health Organization
Speranta Dumitru, Université Paris Descartes
Gilles Dussault, Instituto de Higiene et Medicina Tropical,
Lisa Hirschhorn, Partners in Health
Fitzhugh Mullan, GW University (plenary)
Thomas Pogge,
John Roemer,
Peter Suter,
Jonathan Wolff,
SCHEDULE - The 2012 Academy will be in session all day from Monday, 18th June, to Friday 22nd June.
TARGET AUDIENCE
Young scholars (post-doctoral fellows, junior faculty, and advanced graduate students) in philosophy, political science, economics and other social sciences, the biomedical sciences, and global health; and practitioners and professionals in health policy and global health
HOW TO APPLY
Attendance is limited to 40 participants. Participation is free, but a fee of CH 550, required of all those accepted for participation, covers course documentation, 5 nights of accommodation, 5 lunches and 4 dinners, and local transportation.
Your application form at http://bit.ly/zP8eDN should be accompanied by a short CV, one writing sample, and a one-paragraph description of your current research interests.
VENUE & CONTACT ADDRESS
Brocher Foundation -
Rte d’Hermance, 471, CP 70
CH-1248 Hermance
* * *
This message from the Pan American Health Organization, PAHO/WHO, is part of an effort to disseminate
information Related to: Equity; Health inequality; Socioeconomic inequality in health; Socioeconomic
health differentials; Gender; Violence; Poverty; Health Economics; Health Legislation; Ethnicity; Ethics;
Information Technology - Virtual libraries; Research & Science issues. [DD/ KMC Area]
“Materials provided in this electronic list are provided "as is". Unless expressly stated otherwise, the findings
and interpretations included in the Materials are those of the authors and not necessarily of The Pan American
Health Organization PAHO/WHO or its country members”.
------------------------------------------------------------------------------------
PAHO/WHO Website
Equity List - Archives - Join/remove: http://listserv.paho.org/Archives/equidad.html
Twitter http://twitter.com/eqpaho
IMPORTANT: This transmission is for use by the intended
recipient and it may contain privileged, proprietary or
confidential information. If you are not the intended
recipient or a person responsible for delivering this
transmission to the intended recipient, you may not
disclose, copy or distribute this transmission or take
any action in reliance on it. If you received this transmission
in error, please dispose of and delete this transmission.
Thank you.
1 comment:
Aurobindo Pharma gets U.S. FDA nod for Ranolazine Extended Release Oral Tablet
Currency Tips
Post a Comment